Cross-laboratory replication of pseudomyxoma peritonei tumor microbiome reveals reproducible microbial signatures

Victoria F Nieciecki1,2, Faith C Blum3, Ryan C Johnson4

  • 1Graduate Program in Cell & Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.

Msphere
|February 20, 2025
PubMed

Insights

This study developed a robust workflow to identify reproducible tumor microbiomes in low-biomass samples, like pseudomyxoma peritonei (PMP). Replication confirmed microbial signatures and identified patient-specific taxa, improving low microbial biomass research.

Area of Science:

  • Microbiology
  • Oncology
  • Bioinformatics

Background:

  • Cancer-specific microbial communities colonize tumor tissues, but low-biomass signals are challenging to distinguish from contamination.
  • Pseudomyxoma peritonei (PMP) is a cancer characterized by widespread mucus-secreting cells, often originating from appendiceal tumors.

Purpose of the Study:

  • To develop a robust workflow for identifying reproducible tumor microbiomes in low-biomass samples.
  • To characterize the microbiome of PMP tumors and identify reproducible microbial signatures.
  • To assess the impact of preoperative chemotherapy on tumor microbiome diversity.

Main Methods:

  • Characterized the microbiome of 70 PMP tumors and six normal peritoneal tissues.
  • Utilized laboratory and independent laboratory replication for DNA extraction and sequencing.
  • Analyzed microbial signatures, including core and patient-specific taxa, and correlated with clinical data.

Main Results:

  • Identified reproducible microbial signatures in PMP tumors, including core taxa potentially from surgical contamination and patient-specific taxa linked to colorectal cancer.
  • Found that preoperative chemotherapy reduced tumor microbiome diversity.
  • Demonstrated that sample replication is crucial for investigating low-biomass tumor-associated microbial communities.

Conclusions:

  • A robust workflow using independent sample replication can identify reproducible microbial signatures in low-biomass tumor tissues.
  • PMP tumors harbor reproducible microbial communities, with some taxa associated with colorectal cancer.
  • Future tumor microbiome studies should incorporate replication to enhance signal detection and reproducibility.